Targeted therapy for ovarian cancer
Targeted therapy is a newer type of cancer treatment that uses drugs or other substances to find and attack cancer cells while doing little damage to normal cells. Each type of targeted therapy works differently, but all change the way a cancer cell grows, divides, repairs itself, or acts.
The targeted therapy drug that has been studied the most in ovarian cancer is bevacizumab (Avastin®). Bevacizumab isn’t approved by the US Food and Drug Administration (FDA) to treat ovarian cancer, but it has been approved to treat other cancers. It may be a treatment option in some cases. Studies of other targeted therapy drugs that could be used for ovarian cancer are going on.
Last Medical Review: 08/08/2014
Last Revised: 08/15/2014